Hemopure Addresses the Serious Threat Posed to Blood Supplies by the Emerging Infectious Diseases

While blood transfusion will always be the gold standard of treatment, there is an obvious need for alternative products, such as Hemopure, in the US healthcare system and emergency preparedness.

SOUDERTON, PA - March 26, 2020 /MarketersMedia/ —

Ensuring a regular and quality blood supply is a constant challenge for healthcare systems worldwide. In the US, according to data from the American Red Cross, a mere 3% of citizens normally donate blood even though 38% of the population are eligible to donate; Every two seconds, someone requires a transfusion; And a single donation could save as many as three lives. The current US blood supplies can barely meet the needs of patients, many of whom rely on transfusions to survive, either because of severe trauma, life-threatening medical conditions, or surgical complications. In times of national emergencies, such as pandemics or major natural disasters, the lack of sufficient supplies can lead to unnecessary loss of life, exacerbating already tragic situations. Hence, the strong advocacy from the medical and scientific communities for the development and use of blood substitutes, such as the oxygen-carrying solution Hemopure, manufactured by Hemoglobin Oxygen Therapeutics, a clinical-stage biotech company headquartered in Souderton, PA.

While clinicians have been able to use evidence-based medical and surgical concepts to optimize hemostasis and minimize blood loss in an effort to improve patient outcomes, the number of donors over the past few years has dropped significantly, more than negating any savings. An additional risk, this time to the safety of US blood supply, is that despite what officials describe as near-Herculean efforts to screen donated blood for the emerging viruses, the nation's blood supply is not immune from contaminations as was the case a few years ago when the CDC announced that several cases of West Nile illness were attributed to blood transfusions that contained tainted blood.

The push to develop alternatives to traditional blood transfusions has intensified in the 21st century amidst the global population growth and aging, the emergence of new infectious agents, and the seemingly rising number of natural disasters due to climate change. Not only is the number of donors insufficient to meet demand, but the nature of blood is such that it cannot be readily stockpiled, as refrigerated blood has a shelf-life of only 42 days. With multiple positive medical journal articles already published on Hemopure, its characteristics - including no blood typing or cross matching as well as three-year stability without the need for refrigeration - are ideal for out-of-hospital applications and stockpiling for national emergencies. It is no surprise then that the US Department of Defense is funding a large prehospital clinical trial to evaluate use of Hemopure as a resuscitation fluid in conjunction with freeze-dried plasma.

Currently, Hemopure is stocked and used at several hospitals as an investigational product, under FDA’s authorized expanded access protocols, for the treatment of severe anemia when blood transfusions are not an option. Interestingly, regulatory authorities in South Africa and Russia have already granted market approval for Hemopure for the treatment of perioperative anemia. “While blood transfusion will always be the gold standard of treatment, there is also an obvious need for alternative products, such as Hemopure, in our healthcare system and emergency preparedness,” experts at BloodSupplySolution.com assert. “Stakeholders in government, academic medicine and industry should find a way to work together to make this happen proactively rather than reactively.”

Blood Supply Solution – Oxygen-Carrying Blood Substitutes: http://bloodsupplysolution.com

Expanded Access Protocol Using HBOC-201 – ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02684474

Contact Info:
Name: Gail Weiss
Email: Send Email
Organization: BloodSupplySolution.com
Phone: 267-871-9577
Website: http://bloodsupplysolution.com

Source URL: https://marketersmedia.com/hemopure-addresses-the-serious-threat-posed-to-blood-supplies-by-the-emerging-infectious-diseases/88951297

Source: MarketersMedia

Release ID: 88951297

More News From Money - Morning Dispatcher

Sultan Qaboos bin Said, who modernized Oman, dies at 79

Apr 2, 2020

DUBAI, United Arab Emirates — Oman’s Sultan Qaboos bin Said, the Mideast's longest-ruling monarch who seized power in a 1970 palace coup and pulled his Arabian sultanate into modernity while carefully balancing diplomatic ties between adversaries Iran and the U.S., has died. He was 79. The British-educated, reclusive sultan reformed a nation that was home to only three schools and harsh laws banning electricity, radios, eyeglasses and even umbrellas when he took the throne. Under his reign, Oman became known as a welcoming tourist destination and a key Mideast interlocutor, helping the U.S. free captives in Iran and Yemen and...

On streets of Tehran, relief for now at no wider conflict

Apr 2, 2020

TEHRAN, Iran — Iranian newspapers proclaimed the country's attack on U.S. forces in Iraq to be "a dark night for Americans," and Washington's "first admission of failure in history." On the bustling streets of Tehran, however, there was relief Thursday that neither side appeared primed for war. “War is not something like the ‘Call of Duty’ game," said Dara Shojaei, a 23-year-old architecture student. “It's not a game you can play to win. There's no winner.” But with the relief came some mixed feelings about how far Iran should go to avenge the killing of Revolutionary Guard Gen. Qassem Soleiman,...

Soleimani, a general who became Iran icon by targeting US

Apr 2, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...

Yemeni town thrives on extortion and torture of migrants

Apr 2, 2020

RAS AL-ARA, Yemen — Zahra struggled in the blue waters of the Gulf of Aden, grasping for the hands of fellow migrants. Hundreds of men, women and teenagers clambered out of a boat and through the surf emerging, exhausted, on the shores of Yemen. The 20-year-old Ethiopian saw men armed with automatic rifles waiting for them on the beach and she clenched in terror. She had heard migrants' stories of brutal traffickers, lurking like monsters in a nightmare. They are known by the Arabic nickname Abdul-Qawi — which means Worshipper of the Strong. "What will they do to us?" Zahra...

Saudi energy minister: Saudi Aramco's public offering 'soon'

Apr 2, 2020

RIYADH, Saudi Arabia — A planned stock offering of a small part of state-run oil giant Saudi Aramco "will come soon" and only at the direction of Saudi Arabia's crown prince, the kingdom's energy minister said Wednesday, further underlining the power of the 34-year-old royal. The minister, Prince Abdulaziz bin Salman, did not address reports that Aramco shares will begin to be traded on Riyadh's Tadawul stock market in December, but like Aramco itself, he did not dispute the initial public offering dates reported the day before by a Saudi-owned satellite news channel. However, there have been repeated delays to...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress